An eye toward the clinic, Israel’s Compugen works to transform itself admin June 8, 2017 Blog Read more: https://www.bioworld.com/report/BWT053017Compugen.pdf You Might Also Like Mylan buys rights to Israel-developed Multiple Sclerosis treatment April 12, 2018 BiolineRx buys UK co Agalimmune March 30, 2017 Biosensorix pens pact to develop rapid dengue, stroke tests February 27, 2018
